FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approved Biogen's supplemental application for Tecfidera (dimethyl fumarate), resulting in a label change for this multiple sclerosis therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

SUPPL AP for TECFIDERA (DIMETHYL FUMARATE)